Beijing Hemu Biotechnology Co.

BiotechnologySeries ABeijing, Chinahemubio.com

Latest round

Series A

Last raised

Nov 2025

Total raised

$2.2M

Investors

5

About Beijing Hemu Biotechnology Co.

Founded in 2022 and based in Beijing, China, Hemu Biotechnology is an animal vaccine manufacturer, focusing on the research and development of novel mRNA vaccines for animals. It has launched more than ten R&D pipelines, including vaccines for pigs, cattle, and pets, aiming to improve animal health protection. The company provides animal vaccines. The company generates revenue from supplying animal vaccines.

Who invested in Beijing Hemu Biotechnology Co.

5 investors across 3 rounds

See all investors in Beijing Hemu Biotechnology Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Nov 4, 2025

    Amount

    Undisclosed

    Investors

    Locked

  2. Angel

    Dec 13, 2022

    Amount

    $2.2M

    Investors

    Locked

  3. Angel

    Oct 20, 2022

    Amount

    Undisclosed

    Investors

    Locked

Questions about Beijing Hemu Biotechnology Co.

Who invested in Beijing Hemu Biotechnology Co.?

Beijing Hemu Biotechnology Co. has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Beijing Hemu Biotechnology Co. raised?

Beijing Hemu Biotechnology Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Beijing Hemu Biotechnology Co. last raise money?

Beijing Hemu Biotechnology Co.'s most recent round on record is a Series A, in Nov 2025.

What does Beijing Hemu Biotechnology Co. do?

Founded in 2022 and based in Beijing, China, Hemu Biotechnology is an animal vaccine manufacturer, focusing on the research and development of novel mRNA vaccines for animals.

Where is Beijing Hemu Biotechnology Co. headquartered?

Beijing Hemu Biotechnology Co. is headquartered in Beijing, China.

Which VCs invest in companies like Beijing Hemu Biotechnology Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Beijing Hemu Biotechnology Co.'s stage. Their profiles are linked below.

Raising like Beijing Hemu Biotechnology Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.